Under the terms of the agreement, the methods that will come out of this partnership will be made available to other domestic generics manufacturers. Read More

Glenmark said it will engage with the FDA to resolve the deficiencies observed during the inspection. Read More

The investment is the largest to date for Takeda in Belgium. Read More

The new plant is expected to be operational in the first half of 2023. Read More

The new site is likely to be up and running by 2026. Read More

To stretch the available doses, the FDA issued an emergency authorization that allows for a one-fifth dose to be administered beneath the top layer of the skin. Read More

A bivalent vaccine has not yet been approved by the FDA. Read More

U.S. distribution is expected to begin shortly. Read More

The facility will continue research into the messenger RNA technology that underpins the Pfizer-BioNTech COVID-19 vaccine. Read More

The U.S. has a limited supply of the Jynneos vaccine. Read More

The FDA has granted vamorolone Orphan Drug status, as well as Fast Track and Rare Pediatric Disease designations. Read More